BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12414910)

  • 1. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus.
    Katsuki A; Sumida Y; Urakawa H; Gabazza EC; Murashima S; Morioka K; Kitagawa N; Tanaka T; Araki-Sasaki R; Hori Y; Nakatani K; Yano Y; Adachi Y
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5332-5. PubMed ID: 12414910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
    Yokoyama H; Emoto M; Fujiwara S; Motoyama K; Morioka T; Komatsu M; Tahara H; Koyama H; Shoji T; Inaba M; Nishizawa Y
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1481-4. PubMed ID: 15001651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
    Yokoyama H; Emoto M; Fujiwara S; Motoyama K; Morioka T; Komatsu M; Tahara H; Shoji T; Okuno Y; Nishizawa Y
    Diabetes Care; 2003 Aug; 26(8):2426-32. PubMed ID: 12882874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.
    Katsuki A; Sumida Y; Gabazza EC; Murashima S; Furuta M; Araki-Sasaki R; Hori Y; Yano Y; Adachi Y
    Diabetes Care; 2001 Feb; 24(2):362-5. PubMed ID: 11213893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
    Emoto M; Nishizawa Y; Maekawa K; Hiura Y; Kanda H; Kawagishi T; Shoji T; Okuno Y; Morii H
    Diabetes Care; 1999 May; 22(5):818-22. PubMed ID: 10332688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between HOMA-IR and insulin sensitivity index determined by hyperinsulinemic-euglycemic clamp analysis during treatment with a sodium-glucose cotransporter 2 inhibitor.
    So A; Sakaguchi K; Okada Y; Morita Y; Yamada T; Miura H; Otowa-Suematsu N; Nakamura T; Komada H; Hirota Y; Tamori Y; Ogawa W
    Endocr J; 2020 May; 67(5):501-507. PubMed ID: 32023587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homeostasis model assessment of insulin resistance for evaluating insulin sensitivity in patients with type 2 diabetes on insulin therapy.
    Okita K; Iwahashi H; Kozawa J; Okauchi Y; Funahashi T; Imagawa A; Shimomura I
    Endocr J; 2013; 60(3):283-90. PubMed ID: 23149658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.
    Rabasa-Lhoret R; Bastard JP; Jan V; Ducluzeau PH; Andreelli F; Guebre F; Bruzeau J; Louche-Pellissier C; MaItrepierre C; Peyrat J; Chagné J; Vidal H; Laville M
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4917-23. PubMed ID: 14557474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes.
    Sarafidis PA; Lasaridis AN; Nilsson PM; Pikilidou MI; Stafilas PC; Kanaki A; Kazakos K; Yovos J; Bakris GL
    J Hum Hypertens; 2007 Sep; 21(9):709-16. PubMed ID: 17443211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea.
    Kang ES; Yun YS; Park SW; Kim HJ; Ahn CW; Song YD; Cha BS; Lim SK; Kim KR; Lee HC
    Metabolism; 2005 Feb; 54(2):206-11. PubMed ID: 15690315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPISE and other fasting indexes of insulin resistance: risks of coronary heart disease or type 2 diabetes. Comparative cross-sectional and longitudinal aspects.
    Cederholm J; Zethelius B
    Ups J Med Sci; 2019 Nov; 124(4):265-272. PubMed ID: 31694444
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model.
    Chen H; Sullivan G; Quon MJ
    Diabetes; 2005 Jul; 54(7):1914-25. PubMed ID: 15983190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between surrogate indices of insulin sensitivity and resistance, and the hyperinsulinaemic euglycaemic glucose clamp in urban South African blacks with and without coronary artery disease.
    Ntyintyane L; Panz V; Raal F; Gill G
    Diab Vasc Dis Res; 2010 Apr; 7(2):151-7. PubMed ID: 20382779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp.
    Moura FA; Carvalho LS; Cintra RM; Martins NV; Figueiredo VN; Quinaglia e Silva JC; Almeida OL; Coelho OR; Sposito AC
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E399-403. PubMed ID: 24347056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.
    Ohkura T; Shiochi H; Fujioka Y; Sumi K; Yamamoto N; Matsuzawa K; Izawa S; Kinoshita H; Ohkura H; Kato M; Taniguchi S; Yamamoto K
    Cardiovasc Diabetol; 2013 Jan; 12():21. PubMed ID: 23339473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QUICKI is useful for following improvements in insulin sensitivity after therapy in patients with type 2 diabetes mellitus.
    Katsuki A; Sumida Y; Gabazza EC; Murashima S; Urakawa H; Morioka K; Kitagawa N; Tanaka T; Araki-Sasaki R; Hori Y; Nakatani K; Yano Y; Adachi Y
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2906-8. PubMed ID: 12050271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment.
    Ikeda Y; Suehiro T; Nakamura T; Kumon Y; Hashimoto K
    Endocr J; 2001 Feb; 48(1):81-6. PubMed ID: 11403106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique.
    Straczkowski M; Stepień A; Kowalska I; Kinalska I
    Med Sci Monit; 2004 Aug; 10(8):CR480-4. PubMed ID: 15277999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes.
    Otowa-Suematsu N; Sakaguchi K; Kaneko A; Ito J; Morita Y; Miura H; Yamada T; So A; Komada H; Okada Y; Hirota Y; Tamori Y; Ogawa W
    J Diabetes Investig; 2021 Dec; 12(12):2197-2202. PubMed ID: 34081831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.